To measure the extent of PDX DCIS in vivo growth, mammary glands containing xenografted lesions were serially sectioned (the entire gland, up to 100 sections) and stained by IF using human‐specific antibodies against CK19. The gene discussed is KRT19; the disease is ductal breast carcinoma in situ.